Hamps Bio (BOM:544312) Operating Margin %: -14.83% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544312 Hamps Bio Ltd BOM:544312
12 GF Score
Price ₹22.50
! 4 Warning Signs
View Full Analysis

What is Hamps Bio Operating Margin %?

Hamps Bio BOM:544312 -2.17% 12 Operating Margin % is -14.83% as of Mar. 2026. GuruFocus rates BOM:544312 with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Hamps Bio ranks worse than 78.31% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. Hamps Bio's Operating Income for the six months ended in Mar. 2026 was ₹-6.65 Mil. Hamps Bio's Revenue for the six months ended in Mar. 2026 was ₹44.83 Mil. Therefore, Hamps Bio's Operating Margin % for the quarter that ended in Mar. 2026 was -14.83%.

The historical rank and industry rank for Hamps Bio's Operating Margin % or its related term are showing as below:

BOM:544312' s Operating Margin % Range Over the Past 10 Years
Min: -9.25   Med: 5.88   Max: 14.05
Current: -9.24


BOM:544312's Operating Margin % is ranked worse than
78.31% of 664 companies
in the Healthcare Providers & Services industry
Industry Median: 5.01 vs BOM:544312: -9.24

Hamps Bio's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Hamps Bio's Operating Income for the six months ended in Mar. 2026 was ₹-6.65 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-7.83 Mil.

Warning Sign:

Hamps Bio Ltd has recorded a loss in operating income at least once over the past 3 years.


Hamps Bio  (BOM:544312) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Hamps Bio Operating Margin % Related Terms


Hamps Bio Operating Margin % Historical Data

* Premium members only.

The historical data trend for Hamps Bio's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hamps Bio Operating Margin % Chart

Hamps Bio Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Operating Margin %
5.44 10.69 14.05 5.88 -9.25

Hamps Bio Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Operating Margin % Get a 7-Day Free Trial 0.00 10.10 1.11 -2.96 -14.83

Hamps Bio Operating Margin % Competitor Comparison

For the Pharmaceutical Retailers subindustry, Hamps Bio's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamps Bio Operating Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hamps Bio's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Hamps Bio's Operating Margin % falls into.


BOM:544312
12GF Score
Hamps Bio Ltd BOM:544312
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hamps Bio Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Hamps Bio's Operating Margin % for the fiscal year that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (A: Mar. 2026 ) / Revenue (A: Mar. 2026 )
=-7.838 / 84.746
=-9.25 %

Hamps Bio's Operating Margin % for the quarter that ended in Mar. 2026 is calculated as

Operating Margin %=Operating Income (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=-6.648 / 44.831
=-14.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of -14.83% mean?
Hamps Bio (BOM:544312) has a Operating Margin % of -14.83% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Hamps Bio and its competitors. According to the industry distribution chart, Hamps Bio ranks #520 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 78.3%.
Is Hamps Bio's Operating Margin % too high?
Hamps Bio's current Operating Margin % is -14.83%. Based on the distribution chart, Hamps Bio ranks #520 out of 664 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Hamps Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Hamps Bio's Operating Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Hamps Bio ranks #520 out of 664 companies for Operating Margin %. This places Hamps Bio in the lower half of its industry. The industry median Operating Margin % is 5.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 5.01, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Hamps Bio and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 5.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hamps Bio's current Operating Margin % is -14.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hamps Bio stock overvalued right now?
Hamps Bio (BOM:544312) has a current Operating Margin % of -14.83%. The current Operating Margin % is -14.83%. Hamps Bio's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Hamps Bio (BOM:544312), the current Operating Margin % is -14.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hamps Bio Business Description

Address Plot no. C1-B-106, Near Mama Bhanja Factory, Bhatpore GIDC, Adajan Dn, Surat, GJ, IND, 394510
Hamps Bio Ltd is engaged in the ethical marketing and distribution of pharmaceutical formulation products. Its product include tablets, syrups, capsules, injectables, oil, gel and powder used as medicine and nutrition supplements as well as the manufacturing of freeze dried and frozen products such as fruits, vegetables, herbs and flowers. The company segment includes Manufacturing, trading and distribution of Pharmaceutical formulation products and Manufacturing of Freeze dried and frozen products like fruits, vegetables, herbs, flowers, etc. Key revenue is generated from Medicine Products.
12GF Score

Get the complete analysis for BOM:544312

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹22.50
Price